/
Hosted by  Blood   & Marrow Transplant Information Network (BMT InfoNet) Hosted by  Blood   & Marrow Transplant Information Network (BMT InfoNet)

Hosted by Blood & Marrow Transplant Information Network (BMT InfoNet) - PowerPoint Presentation

Tornadomaster
Tornadomaster . @Tornadomaster
Follow
342 views
Uploaded On 2022-08-03

Hosted by Blood & Marrow Transplant Information Network (BMT InfoNet) - PPT Presentation

Tuesday November 9 2021 COVID19  Precautions Vaccines and Treatments for Transplant Recipients bmtinfonetorg 8885977674 helpbmtinfonetorg Many thanks to Incyte for its support of this webinar ID: 934493

transplant covid vaccines recipients covid transplant recipients vaccines patients vaccine amp protection risk post disease pfizer shown years cdc

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "Hosted by Blood & Marrow Transpla..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

Slide1

Hosted by

Blood

& Marrow Transplant Information Network (BMT InfoNet)Tuesday November 9, 2021

COVID-19:  Precautions, Vaccines and Treatments for Transplant Recipients

bmtinfonet.org ✦ 888-597-7674 ✦ help@bmtinfonet.org

Many thanks to Incyte for its support of this webinar

.

Slide2

COVID-19: Precautions, Vaccines, and Treatments for Transplant Recipients

Alyssa R. Letourneau MD, MPH

Areej El-Jawahri MDMassachusetts General HospitalClick to add text

Slide3

Outline

Update on state of the nation with COVID-19

COVID-19 in Transplant RecipientsVaccine Recommendations in Transplant RecipientsHow to Treat COVID-19 in Transplant RecipientsCommon Myths about COVID-19

Slide4

COVID-19

COVID-19 is the clinical disease caused by SARS-COV-2 virus

First identified in 2019, there are now over 219 million cases worldwide

Slide5

COVID-19

As of 11/6/2021: 46,358,362 cases US,

749,846 deathsApproximately 75,000 new cases per day in the United States now

Slide6

COVID-19

Slide7

COVID-19 in Transplant Recipients

Multiple studies since the beginning of the pandemic with relatively consistent findings:

75%-80% transplant recipients are hospitalized with COIVD-1921% have severe illness Mortality: 22-35% mortalityHigher risk of COVID-19 hospitalization and mortality in patients with blood cancers

Slide8

COVID-19 in Transplant Recipients

Risk factors for worse outcomes:

Older age > 40 years, male recipientsFirst year post-transplantBeing treated with immunosuppressionPoor performance statusRecent receipt of anti-cancer treatment in the past yearPatients who are > 2 years out from transplant and off immunosuppression similar risk to general population

Slide9

COVID-19 in Transplant Recipients

Several complications have been reported post COVID-19 infection in transplant recipients

Blood clotsKidney and liver problemsInflammation of heart muscle (myocarditis)Post-acute COVID-19 syndromeExacerbation of graft-versus-host disease (GVHD) symptoms?

Slide10

Vaccine Recommendations in Transplant Recipients

Patients should receive COVID-19 vaccine > 3 months after autologous stem cell transplantation

Allogeneic stem cell transplantation recipients should discuss with their doctor, they may delay vaccines until 4-6 months post-HCTVaccine response lower in transplant recipients compared to normal population

Slide11

Available Vaccines

mRNA Vaccines

Pfizer-BioNTechModernaNon-replicating viral vector vaccineJohnson & Johnson / Janssen (J&J)

Slide12

Do These Vaccines Work?

Yes!

They are about 94-95% effective (especially mRNA vaccines)Studies have shown that these vaccines are also effective in immunocompromised patients (70-80% effective)Some data to suggest better response to the mRNA vaccines (Pfizer & Moderna) in transplant recipients

Slide13

Are These Vaccines Safe?

Yes!

There are common side effects and rare adverse eventsLocal reaction: pain at injection site, localized swelling, resolves within a few daysSystemic reaction: fatigue, headache, muscle pain, chills, and joint pains, resolves within a few daysRare adverse reactions: blood clots (J&J), myocarditis (Moderna/Pfizer), very rare

Slide14

Vaccine Recommendations in Transplant Recipients

Third dose has been shown to increase immunity to COVID-19

Who should get a booster / additional dose?65 years of age or olderTransplant recipients who are < 2 years from transplantTransplant recipients with chronic GVHD or those on immunosuppression Patients can mix and match between vaccines for boosterRegardless of the above, if you got J&J you should get a booster  consider getting Moderna or Pfizer for your booster post-transplant

Slide15

How to protect yourself and others?

Wear a mask in public settings!! Regular masks are fine

Get vaccinated, these vaccines are safe and effectiveImmunocompromised patients should get a booster vaccineMake sure your family, kids, and friends get vaccinated

Slide16

COVID-19 Treatment

Mild to moderate disease – outpatient setting

Supportive care to help relieve symptoms. People with mild symptoms can recover at homeMonoclonal antibodies: beneficial especially in patients at risk for severe illness (i.e., transplant recipients), helpful as early as possible in the illness course (ideally < 7 days)Promising new oral antiviral Paxlovid (Pfizer): very promising!

Slide17

COVID-19 Treatment

Moderate to severe disease – hospitalized patients

Remdesivir – for COVID-19 requiring hospital stayDexamethasone: decrease risk of dying in hospitalized patients with COVID-19 on oxygenOther agents to reduce systemic inflammation have been used with mixed results. Unclear if/how these agents help patients who are already immunosuppressedMonoclonal antibodies: sometimes used on a case-by-case basis for patients not mounting their own response.

Slide18

Myths about COVID-19

Myth

AnswerI would like to take hydroxychloroquine or azithromycin to treat or prevent COVID-19Data have shown that these drugs are simply not effectiveI worry about the long-term effects of getting the COVID-19 vaccineNo data to support long-term effects of vaccination. Long-term effects of the COVID-19 virus are likely much worse.

Colin Powell was vaccinated and still died of COVID-19. There is no point in getting the vaccine.Patients who are very immunocompromised may not respond to the vaccine, but even a little bit of protection is better than nothing. I am so immunocompromised, there is no point in getting the vaccine.Studies have shown that even patients who are immunocompromised are getting some protection from the vaccine. Discuss with your doctor.

Slide19

Additional Questions about COVID-19

Question

AnswerWhere should my antibody level be? Should I have it tested?It’s not clear what antibody level provides protection. We advise against antibody testing outside clinical trials. Will we need ongoing boosters / additional vaccines?Unknown at this time, but it seems likely.

I have had COVID-19, should I get the vaccine?Yes! Studies suggest that protection from the vaccine is stronger and longer lasting than immune protection from the virus.

Slide20

Centers for Disease Control (CDC):

https://www.cdc.gov/coronavirus/2019-ncov/index.html

How to protect yourself from the CDC: https://www.cdc.gov/coronavirus/2019-ncov/prepare/prevention.htmlCOVID-19 Questions – Immunization Action Coalition / Ask the experts: https://www.immunize.org/askexperts/experts_cov.aspResources